| Ytd | -85.96% | |
| 1y | -96.87% |
| Open | 4.53 | Prev Close | 4.55 | Low | 4.10 | High | 4.79 | Mkt Cap | 15.75M |
| Vol | 68.19K | Avg Vol | 94.88K | EPS | -12.56 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.42 | Short Ratio | 0.08 | Inst. Own | 37.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.74 | 200-d Avg | 5.97 | 1yr Est | 0.00 |
PBM News
Benuvia operates an 83,000-square-foot, DEA-registered controlled-substance manufacturing facility i
Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade iboga
The term sheet is binding on the parties and is to be superseded by a definitive agreement, which th
Binding term sheet with PsyLabs provides Psyence BioMed's Texas subsidiary with exclusive U.S. devel
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 millio
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 millio
HIGHLIGHTS Texas-based company established as dedicated U.S. vehicle for regulated ibogaine developm
Commercial-stage medical device manufacturer Modular Medical Inc. (NASDAQ:MODD) recently signed a si
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical developm
Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday'
MINNEAPOLIS--(BUSINESS WIRE)--Tredium Solutions, a provider of pharmacy benefit management (PBM) tec
Psyence BioMed Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceu
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or th
LaCorium AcquisitionThe Company today is also announcing a definitive agreement to acquire LaCorium
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Pacific Bay Minerals Ltd. (TSXV: PBM)
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex
Dosing initiates clinical evaluation of NPX-5, a GMP-compliant, nature-derived psilocybin candidate
Psyence Biomedical faces a double-digit decline Tuesday as traders lock in gains following a massive
Psyence Biomedical stock faces profit-taking on Tuesday after a massive rally fueled by a Trump exec
Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-
Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed"
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $1
US stocks rise, Dow gains 600 points. NASDAQ up 1.05% and S&P 500 up 0.74%. Energy stocks down 4
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical
Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourc
Blaize Holdings rose 24.3% in pre-market trading on $50M contract with NeoTensr & MOU with Winma
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
Calgary, Alberta – TheNewswire - April 14, 2026 – Aurwest Resources Corporation (“ Aurwest ” or the
syence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharma
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed”
Psyence Biomedical (NASDAQ: PBM - Get Free Report) and XBiotech (NASDAQ: XBIT - Get Free Report) are
“The strongest companies are built on the right foundations long before their moment arrives,” says
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharm
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed”